MediTox s.r.o.


Main activities

Non clinical R & D related to ophthalmic diseases (chronic glaucoma), contact dermatitis, osteoarthritis, non-clinical development of vaccines (influenza, adenovirus, etc.), inflammatory bowel diseases, non-alcoholic steatohepatitis (NASH)

Comprehensive non-clinical and toxicological program for assessment of human/veterinary drugs, vaccines, biological products, medical devices and food/feed additives (EMA/ICH/VICH/FDA/ISO), chemical substances and preparations (ECHA)

Models of selected human diseases - chronic glaucoma, contact dermatitis, osteoarthritis, non-clinical development of vaccines, inflammatory bowel diseases, non-alcoholic steatohepatitis,…

Accredited breeding facility (Ref No. 3875/2015-MZE-17214)

MediTox s.r.o.

MediTox s.r.o. is a GLP-certified preclinical contract research organization offering a wide range of preclinical development services taking advantage of wealth of experience in variety of therapeutics areas, biotechnology, chemical and agrochemical industry and research collaboration with universities and research institutions.


MediTox R&D activities are pointed to collaborative scientific and research projects within international and national framework.


The strong points of MediTox ensure personalized and comprehensive contract research (one-stop-shop), high professional standard together with flexibility and competitive pricing.



BIO-EUROPE SPRING, March 23 – 25, 2020, Paris, France

BIO Europe – Spring



Central European BioForum, 20. – 21. May, 2020, Warszawa, Poland

Central European BioForum



MedFIT 2020, 30.06 – 01.07.2020, Grenoble, France

MedFIT 2020



Nordic Life Sciences 2020, September 08 – 09, 2020 Malmő, Sweden

Nordic Life Science Days 2020



CPhI Worldwide 2020, October 13 – 15, Milano, Italy

CPhI Worldwide 2020



BioFIT 2020, December 1 – 3, Strasbourg, France

BioFIT 2020


MediTox s.r.o.

MediTox s.r.o.

MediTox s.r.o.